Clinical Trials Browser

Phase 1/2 × Leukemia, Promyelocytic, Acute × Arsenic Trioxide × Clear all

NCT05497310 2022-10-26

Effectiveness and Safety of Therapy Based on Attenuated ATO Plus Low-Dose ATRA in Patients With APL

Phase 1/2 Unknown

Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT00008697 2013-04-12

Arsenic Trioxide in Treating Patients With Refractory or Recurrent Acute Promyelocytic Leukemia

Phase 1/2 Completed

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute